摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5'-deoxy-4',5-difluoro-2',3'-bis(benzyloxy)uridine | 113548-96-2

中文名称
——
中文别名
——
英文名称
5'-deoxy-4',5-difluoro-2',3'-bis(benzyloxy)uridine
英文别名
5-fluoro-1-[(2R,3R,4S,5S)-5-fluoro-5-methyl-3,4-bis(phenylmethoxy)oxolan-2-yl]pyrimidine-2,4-dione
5'-deoxy-4',5-difluoro-2',3'-bis(benzyloxy)uridine化学式
CAS
113548-96-2
化学式
C23H22F2N2O5
mdl
——
分子量
444.435
InChiKey
HSHWVRLZVYAMAJ-MHXAIHSWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.06
  • 重原子数:
    32.0
  • 可旋转键数:
    7.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    82.55
  • 氢给体数:
    1.0
  • 氢受体数:
    6.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5'-deoxy-4',5-difluoro-2',3'-bis(benzyloxy)uridinepalladium dihydroxide 氢气 作用下, 以 1,4-二氧六环 为溶剂, 反应 10.0h, 以31%的产率得到5-氟-1-(5-氟-3,4-二羟基-5-甲基四氢呋喃-2-基)嘧啶-2,4-二酮
    参考文献:
    名称:
    Synthesis and interaction with uridine phosphorylase of 5'-deoxy-4',5-difluorouridine, a new prodrug of 5-fluorouracil
    摘要:
    5'-Deoxy-4',5-difluorouridine (4'-F-5'-dFUrd) (10) has been synthesized on the basis of the rationale that the labilization of the glycosidic linkage caused by the 4'-fluoro substituent might allow this compound to be a better prodrug form of the anticancer drug 5-fluorouracil (FUra) than is the widely studied fluoropyrimidine 5'-deoxy-5-fluorouridine (5'-dFUrd). The rate of solvolytic hydrolysis of the glycosidic linkage of 4'-F-5'-dFUrd at pH 1 was about 500-fold faster than that of 5'-dFUrd. Since uridine phosphorylase is thought to be the enzyme that causes degradation of 5'-dFUrd in vivo to generate FUra, we compared the substrate interactions of 5'-dFUrd and 4'-F-5'-dUrd with this enzyme. The Vmax for hydrolysis of 4'-F-5'-dFUrd to FUra by uridine phosphorylase was about 5-fold greater than that of 5'-dFUrd, whereas the Km value of 4'-F-5'-dFUrd was 10-fold lower. The combination of these two factors results in 4'-F-5'-dFUrd having a 50-fold higher value of V/K than does 5'-dFUrd. Against L1210 cells in culture, the IC50 value for growth inhibition by 4'-F-5'-dFUrd was 3 X 10(-7) compared to 3 X 10(-6) for 5'-dFUrd.
    DOI:
    10.1021/jm00401a008
  • 作为产物:
    描述:
    1-(5-deoxy-2,3-bis(benzyloxy)-β-D-erythro-pent-4-enofuranosyl)-5-fluorouracil氟化氢吡啶 作用下, 以 四氢呋喃 为溶剂, 反应 1.0h, 以86%的产率得到5'-deoxy-4',5-difluoro-2',3'-bis(benzyloxy)uridine
    参考文献:
    名称:
    Synthesis and interaction with uridine phosphorylase of 5'-deoxy-4',5-difluorouridine, a new prodrug of 5-fluorouracil
    摘要:
    5'-Deoxy-4',5-difluorouridine (4'-F-5'-dFUrd) (10) has been synthesized on the basis of the rationale that the labilization of the glycosidic linkage caused by the 4'-fluoro substituent might allow this compound to be a better prodrug form of the anticancer drug 5-fluorouracil (FUra) than is the widely studied fluoropyrimidine 5'-deoxy-5-fluorouridine (5'-dFUrd). The rate of solvolytic hydrolysis of the glycosidic linkage of 4'-F-5'-dFUrd at pH 1 was about 500-fold faster than that of 5'-dFUrd. Since uridine phosphorylase is thought to be the enzyme that causes degradation of 5'-dFUrd in vivo to generate FUra, we compared the substrate interactions of 5'-dFUrd and 4'-F-5'-dUrd with this enzyme. The Vmax for hydrolysis of 4'-F-5'-dFUrd to FUra by uridine phosphorylase was about 5-fold greater than that of 5'-dFUrd, whereas the Km value of 4'-F-5'-dFUrd was 10-fold lower. The combination of these two factors results in 4'-F-5'-dFUrd having a 50-fold higher value of V/K than does 5'-dFUrd. Against L1210 cells in culture, the IC50 value for growth inhibition by 4'-F-5'-dFUrd was 3 X 10(-7) compared to 3 X 10(-6) for 5'-dFUrd.
    DOI:
    10.1021/jm00401a008
点击查看最新优质反应信息

文献信息

  • AJMERA, SUDHIR;BAPAT, ASHOK R.;STEPHANIAN, EDIC;DANENBERG, PETER V., J. MED. CHEM., 31,(1988) N 6, 1094-1098
    作者:AJMERA, SUDHIR、BAPAT, ASHOK R.、STEPHANIAN, EDIC、DANENBERG, PETER V.
    DOI:——
    日期:——
查看更多